Scholarlink

<p>The new European Society for Cardiology (ESC) guidelines 2025 define the inflammatory myocardial and pericardial syndrome (IMPS) as an umbrella term for inflammatory heart diseases. They emphasize cardiac magnetic resonance imaging (MRI) as a&#xa0;principal diagnostic tool capable of distinguishing active, past and healed inflammation, which is vital for the diagnosis, monitoring, treatment and risk stratification. Symptom-based management pathways, genetic testing, especially in recurrent cases and early detection of red flags are emphasized. The multimodal diagnostic approach includes clinical investigations, biomarkers and echocardiography, with MRI playing a&#xa0;central role; an endomyocardial biopsy remains relevant in unclear or high-risk cases. New forms of treatment, such as anti-interleukin 1 (IL-1) agents and personalized return to sports regimens complement the framework. Interdisciplinary teamwork is crucial, whereby expansion of the infrastructure in Germany is necessary to ensure comprehensive, patient-centered care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Neue Myokarditis und Perikarditis Leitlinie der ESC: Zentrale Rolle der kardiovaskulären Magnetresonanztomographie (Herz-MRT) – DGK-Stellungnahme

  • 期刊论文

  • 发表日期：

    2025年10月30日

查看全文
  • Andreas Schuster,
  • Sören J. Backhaus,
  • Mareike Cramer,
  • Theresa Reiter,
  • Alexander Schulz,
  • Stefanie M. Werhahn,
  • Grigorios Korosoglou,
  • Nadine Abanador-Kamper

摘要

The new European Society for Cardiology (ESC) guidelines 2025 define the inflammatory myocardial and pericardial syndrome (IMPS) as an umbrella term for inflammatory heart diseases. They emphasize cardiac magnetic resonance imaging (MRI) as a principal diagnostic tool capable of distinguishing active, past and healed inflammation, which is vital for the diagnosis, monitoring, treatment and risk stratification. Symptom-based management pathways, genetic testing, especially in recurrent cases and early detection of red flags are emphasized. The multimodal diagnostic approach includes clinical investigations, biomarkers and echocardiography, with MRI playing a central role; an endomyocardial biopsy remains relevant in unclear or high-risk cases. New forms of treatment, such as anti-interleukin 1 (IL-1) agents and personalized return to sports regimens complement the framework. Interdisciplinary teamwork is crucial, whereby expansion of the infrastructure in Germany is necessary to ensure comprehensive, patient-centered care.